9 Meters Biopharma Stock Price

0.0092 (3.53%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 3,889,615
Bid Price 0.2653
Ask Price 0.27
News (1)
Day High 0.27


52 Week Range


Day Low 0.2537
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
9 Meters Biopharma Inc NMTR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0092 3.53% 0.27 19:35:45
Open Price Low Price High Price Close Price Prev Close
0.27 0.2537 0.27 0.2659 0.2608
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,202 3,889,615 $ 0.267465 $ 1,040,336 - 0.1974 - 1.46
Last Trade Time Type Quantity Stock Price Currency
19:58:48 3,000 $ 0.2699 USD


Draw Mode:

9 Meters Biopharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 69.96M 259.11M 255.95M $ - $ - -0.15 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.50M 2.20%

more financials information »

9 Meters Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NMTR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.230.290.2150.23894693,323,1950.0417.39%
1 Month0.230.290.20610.23653823,549,9520.0417.39%
3 Months0.38010.660.19740.31829644,512,701-0.1101-28.97%
6 Months0.690.74440.19740.37744862,799,685-0.42-60.87%
1 Year1.041.460.19740.66731212,275,021-0.77-74.04%
3 Years0.5142.260.19741.044,084,713-0.244-47.47%
5 Years0.5142.260.19741.044,084,713-0.244-47.47%

9 Meters Biopharma Description

9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003 and others.

Your Recent History
9 Meters B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now